#44 Victory or false promises?
This week, more money is being thrown into startups that are harnessing the power of sensors and diagnostic testing to support patients in the comfort of their homes, Amazon wants to get you up and moving to improve your “Movement Health” and is it all good news for patients following approval of the first Alzheimer’s drug in the US since 2003?
News Bites 🥪
What to Listen to 🔊
This week James is joined by Dr Mark Kotter, a neurosurgeon, stem cell biologist and serial entrepreneur. He is the founder and CEO of bit.bio whose ‘opti-ox’ technology allows for the efficient and consistent production of human cells for use in research, drug development, and cell therapy…
In this episode, Matt Venning talks with Dr Bhavagaya Bakshi, CEO and co-founder of C The Signs. C The Signs is a digital tool, primarily for doctors, to support the early identification of patients at risk of cancer. Using AI and advanced algorithms, the platform can identify which cancer or cancers a patient is at risk of and the most appropriate next step – all in less than 30 seconds. Earlier detection and diagnosis results in better outcomes for patients…
1️⃣ Oto, a treatment platform for tinnitus patients, is looking for a Marketing and Community Manager